Organic Chemistry TRIZ Cases

Periodic dosing of oral HIF prolyl hydroxylase inhibitors stabilizes hemoglobin while maintaining iron metabolism balance in anemia treatment.

Substoichiometric sterically hindered base catalysis reduces impurity formation and enhances yield during transesterification.

Integrated distillation and solvent extraction selectively isolate methoxyphenols from bio-oil feedstocks with high purity.

Cycloaliphatic epoxide formulations resolve curing shrinkage stresses while maintaining solubility in polar solvents.

Cesium and manganese promoters stabilize supported silver catalysts, enabling rapid activity recovery after reactor upsets.

Trioxane reaction avoids water formation and hydrolysis, enabling high trimer content for stable diesel fuel additives.

Deleting butyrate and lactate genes in Clostridium redirects glycerol metabolism to 1,3-propanediol, overcoming low yields from reduced co-product formation.

Trivalent PROTACs overcome monovalent limitations by forming stable ternary complexes that ensure rapid, complete BRD2 degradation.

N-substituted beta-carbolinium compounds induce P-glycoprotein expression to enhance amyloid-beta clearance.

A radiation-sensitive composition uses a thioacetal acid generator to enhance line width roughness in resist patterns.

Novel compounds inhibit glycolate oxidase, reducing oxalate production and preventing kidney disease progression in primary hyperoxaluria.

Converting the acid to a mixed anhydride intermediate eliminates by-product formation and boosts yield compared to conventional industrial synthesis routes.

Reacting the lithium salt of 1,2-benzisothiazolin-3-one with alkylating agents achieves greater than 94% selectivity for N-substituted products.

Targeted boundary layer emulsions enhance anti-wear properties in non-motor oil lubricants lacking complex detergent packages.

Aqueous triazine and anionic surfactant composition removes hydrogen sulfide from hydrocarbon streams.

Synthesizing 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid via ultrasonic irradiation for high antioxidant potential.

3-arylindazole compounds inhibit mitogen-activated protein kinase 4 through localized structural modifications.

Antofine from Cynanchum sp. extract inhibits TNF-α and IL-6 to treat arthritis with fewer side effects.

Combining Mcl-1 inhibitors with BRAF drugs downregulates resistance proteins, reversing treatment failure in refractory melanoma.

Asymmetric substituent patterns on benzohydrazide analogs enhance binding affinity for LSD1 and LSD2, resolving insufficient selectivity in current inhibitors.

Specific aryl and heteroaryl groups suppress exciton diffusion to improve emission efficiency.

A chemically amplified resist composition uses specific quaternary ammonium salts to enhance pattern resolution and edge smoothness.

Allosteric inhibitors bind a distinct enzyme pocket to overcome ATP-site homology and achieve selective kinase inhibition.

An artificial hapten couples with carrier proteins to induce high-affinity anti-fentanyl antibodies.

Aqueous RAFT polymerization with sulphur compounds achieves high conversion rates and low polymolecularity indices for mineral dispersion applications.

Copper(I) catalysis simplifies the complex synthesis of cis-configured triazoles, stabilizing active forms for potent anticancer activity.

Tetrahydroquinoline compounds resolve potency and side effect contradictions by inhibiting YAP/TAZ-TEAD activation for safer cancer treatment.

Continuous propylene oxide production uses dynamic formate salt concentration to maintain hydrogen peroxide conversion.

Ligands with specific structural features bind and stabilize the c-MYC promoter G-quadruplex, reducing off-target effects on non-c-MYC genes.

Controlling bisphenol and amine condensation between 10-80C prevents solution solidification while maintaining high product yield.

Replacing nitramines with bistetrazolediol salts eliminates toxicity while maintaining superior explosive power and handling safety.

Liquid-liquid extraction recovers 80-85% of energy by separating trioxane from water without complete evaporation.

Small molecule modulators inhibit GCN2 signaling to restore T cell function, overcoming tumor immune evasion and resistance mechanisms.

Novel imidazole compound acts as a potent GLP-1 receptor agonist with high oral bioavailability.

A triazine-based organic compound with an adamantane-fluorenyl core enhances electron injection and transport in electronic devices.

1,3,4-Oxadiazole sulfamide derivatives selectively inhibit histone deacetylase 6 to avoid Class I enzyme side effects.

Modifying ring structures and substituents expands the therapeutic window of lysine specific demethylase 1 inhibitors while improving druggability.

Segmented pyrrolotriazinone derivatives resolve treatment reliability gaps by providing specific NLRP3 inhibition options.

Continuous organic extraction in a biphasic system yields high-concentration CMF from cellulose, bypassing dilute fermentation steps.

Lewis acid enables direct ester to amide coupling, bypassing complex hydrolysis steps that lower yield and purity.

Formula II compounds selectively bind cereblon, preventing non-specific zinc finger degradation.

Amino-substituted indeno-fused naphthopyrans shift absorption spectra to longer wavelengths, enabling photochromic transformation behind automotive windshields.

Segmenting mixing and reaction into micro-channels reduces synthesis time and energy consumption while maintaining high yield during continuous flow.

Specific molecular motifs increase hole-transport layer thickness without raising operating voltage, improving OLED efficiency and lifetime.

Merging ACE inhibition and nitric oxide donation in addition salts overcomes insufficient blood pressure control in resistant hypertension cases.

Specific aromatic dihydroxy compounds enable thin-wall molding without sacrificing impact strength or transparency.

Aryl sultam derivatives feature a quaternary carbon substituent at group Z to enhance selectivity for the RORc receptor subtype.

Selective ROMK inhibition increases urine volume and sodium excretion to treat hypertension while avoiding metabolic side effects like dyslipidemia.